SBC vs GRNQ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SBC Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SBC Medical Group Holdings Incorporated Common Stock (SBC) driven by superior Valuation, Growth & Margin while GRNQ counters with relative strength in Momentum & Technical. Fundamentally, SBC trades at 9.0x Forward P/E with 39.9% operating margin (+35.1% YoY revenue) versus GRNQ at N/M Forward P/E and -78.7% operating margin (+510.1% YoY). In options structure, SBC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GRNQ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SBC | GRNQ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $574.4M | $14.2M | Larger Scale | SBC |
| Trailing P/E Ratio Valuation | 11.0x | N/M | Lower Multiple | SBC |
| Forward P/E Ratio Valuation | 9.0x | N/M | Lower Multiple | SBC |
| Revenue Growth (YoY) Growth | +35.1% | +510.1% | Higher Growth | GRNQ |
| Operating Margin (TTM) Profitability | 39.9% | -78.7% | Higher Margin | SBC |
| Net Profit Margin Profitability | 27.3% | -127.3% | Higher Margin | SBC |
| Return on Equity (ROE) Capital Efficiency | 19.3% | -15.9% | Higher ROE | SBC |
| 52-Week Range Position Momentum | 52% ($3โ$7) | 30% ($1โ$23) | Stronger Trend | SBC |
| Beta / 30D Volatility Risk Regime | 0.96ฮฒ ยท 159% Vol | -0.65ฮฒ ยท 57% Vol | Lower Realized Risk | GRNQ |
| Unified Institutional Score Composite Signal | 47.2 / 100 (HOLD) | 50.0 / 100 (HOLD) | Higher Composite | GRNQ |